SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-074112
Filing Date
2018-12-20
Accepted
2018-12-20 16:06:39
Documents
5
Period of Report
2018-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41890_18k.htm 8-K 28145
2 EX-1.1 a18-41890_1ex1d1.htm EX-1.1 251764
3 EX-5.1 a18-41890_1ex5d1.htm EX-5.1 10508
4 GRAPHIC g418901kki001.jpg GRAPHIC 7307
5 GRAPHIC g418901kki002.jpg GRAPHIC 3696
  Complete submission text file 0001104659-18-074112.txt   307135
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 181246297
SIC: 2834 Pharmaceutical Preparations